Psyence Biomedical Ltd. (PBM) Secures Exclusive U.S. Ibogaine Licence via Binding Term Sheet
Psyence Biomedical said its Texas unit signed a binding term sheet with PsyLabs for exclusive U.S. licence, supply and distribution of pharmaceutical-grade ibogaine. Milestones total up to ~$1.3M for the first candidate; a definitive deal is due by Nov. 30, 2026.Material DetailsContext by AI Analys…